|
1
|
Elgebaly MM, Prakash R, Li W, et al:
Vascular protection in diabetic stroke: role of matrix
metalloprotease-dependent vascular remodeling. J Cereb Blood Flow
Metab. 30:1928–1938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Niu W and Qi Y: Matrix metalloproteinase
family gene polymorphisms and risk for coronary artery disease:
systematic review and meta-analysis. Heart. 98:1483–1491. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pasterkamp G, Schoneveld AH, Hijnen DJ, et
al: Atherosclerotic arterial remodeling and the localization of
macrophages and matrix metalloproteases 1, 2 and 9 in the human
coronary artery. Atherosclerosis. 150:245–253. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baramova E and Foidart JM: Matrix
metalloproteinase family. Cell Biol Int. 19:239–242.
1995.PubMed/NCBI
|
|
5
|
Romanic AM, White RF, Arleth AJ, et al:
Matrix metalloproteinase expression increases after cerebral focal
ischemia in rats: inhibition of matrix metalloproteinase-9 reduces
infarct size. Stroke. 29:1020–1030. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Matrisian LM: Metalloproteinases and their
inhibitors in matrix remodeling. Trends Genet. 6:121–125. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Skjøt-Arkil H, Barascuk N, Register T and
Karsdal MA: Macrophage-mediated proteolytic remodeling of the
extracellular matrix in atherosclerosis results in neoepitopes: a
potential new class of biochemical markers. Assay Drug Dev Technol.
8:542–552. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yeh JL, Hsu JH, Liang JC, et al:
Lercanidipine and labedipinedilol - a attenuate
lipopolysaccharide/interferon-γ-induced inflammation in rat
vascular smooth muscle cells through inhibition of HMGB1 release
and MMP-2, 9 activities. Atherosclerosis. 226:364–372. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagareddy PR, Rajput PS, Vasudevan H, et
al: Inhibition of matrix metalloproteinase-2 improves endothelial
function and prevents hypertension in insulin-resistant rats. Br J
Pharmacol. 165:705–715. 2012. View Article : Google Scholar :
|
|
10
|
Robinson SC, Scott KA and Balkwill FR:
Chemokine stimulation of monocyte matrix metalloproteinase-9
requires endogenous TNF-alpha. Eur J Immunol. 32:404–412. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vaday GG, Hershkoviz R, Rahat MA, et al:
Fibronectin-bound TNF-alpha stimulates monocyte matrix
metalloproteinase-9 expression and regulates chemotaxis. J Leukoc
Biol. 68:737–747. 2000.PubMed/NCBI
|
|
12
|
Zhang Y, McCluskey K, Fujii K and Wahl LM:
Differential regulation of monocyte matrix metalloproteinase and
TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and
IL-1 beta through prostaglandin-dependent and -independent
mechanisms. J Immunol. 161:3071–3076. 1998.PubMed/NCBI
|
|
13
|
Galis ZS and Khatri JJ: Matrix
metalloproteinases in vascular remodeling and atherogenesis: the
good, the bad, and the ugly. Circ Res. 90:251–262. 2002.PubMed/NCBI
|
|
14
|
Shagdarsuren E, Djalali-Talab Y,
Aurrand-Lions M, et al: Importance of junctional adhesion
molecule-C for neointimal hyperplasia and monocyte recruitment in
atherosclerosis-prone mice-brief report. Arterioscler Thromb Vasc
Biol. 29:1161–1163. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mestas J and Ley K: Monocyte-endothelial
cell interactions in the development of atherosclerosis. Trends
Cardiovasc Med. 18:228–232. 2008. View Article : Google Scholar
|
|
16
|
Romanic AM and Madri JA: The induction of
72-kD gelatinase in T cells upon adhesion to endothelial cells is
VCAM-1 dependent. J Cell Biol. 125:1165–1178. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee E, Grodzinsky AJ, Libby P, et al:
Human vascular smooth muscle cell-monocyte interactions and
metalloproteinase secretion in culture. Arterioscler Thromb Vasc
Biol. 15:2284–2289. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Amorino GP and Hoover RL: Interactions of
monocytic cells with human endothelial cells stimulate monocytic
metalloproteinase production. Am J Pathol. 152:199–207.
1998.PubMed/NCBI
|
|
19
|
Benjamin MM and Khalil RA: Matrix
metalloproteinase inhibitors as investigative tools in the
pathogenesis and management of vascular disease. EXS. 103:209–279.
2012.PubMed/NCBI
|
|
20
|
Mannello F, Medda V, Ligi D and Raffetto
JD: Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase
secretion and activity: possible pharmacological role against
collagen degradation in vascular chronic diseases. Curr Vasc
Pharmacol. 11:354–365. 2013. View Article : Google Scholar
|
|
21
|
Legein B, Temmerman L, Biessen EA and
Lutgens E: Inflammation and immune system interactions in
atherosclerosis. Cell Mol Life Sci. 70:3847–3869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Desai A, Darland G, Bland JS, et al:
META060 attenuates TNF-α-activated inflammation,
endothelial-monocyte interactions, and matrix metalloproteinase-9
expression, and inhibits NF-κB and AP-1 in THP-1 monocytes.
Atherosclerosis. 223:130–136. 2013. View Article : Google Scholar
|
|
23
|
Roycik MD, Myers JS, Newcomer RG and Sang
QX: Matrix metalloproteinase inhibition in atherosclerosis and
stroke. Curr Mol Med. 13:1299–1313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilson HM, Barker RN and Erwig LP:
Macrophages: promising targets for the treatment of
atherosclerosis. Curr Vasc Pharmacol. 7:234–243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong YJ, Cho HJ, Whang K, et al: Melittin
has an inhibitory effect on TNF-α-induced migration of human aortic
smooth muscle cells by blocking the MMP-9 expression. Food Chem
Toxicol. 50:3996–4002. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hojo Y, Ikeda U, Takahashi M, et al:
Matrix metalloproteinase-1 expression by interaction between
monocytes and vascular endothelial cells. J Mol Cell Cardiol.
32:1459–1468. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matías-Román S, Gálvez BG, Genís L, et al:
Membrane type 1-matrix metalloproteinase is involved in migration
of human monocytes and is regulated through their interaction with
fibronectin or endothelium. Blood. 105:3956–3964. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mostafa Mtairag E, Chollet-Martin S,
Oudghiri M, et al: Effects of interleukin-10 on
monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion.
Cardiovasc Res. 49:882–890. 2001. View Article : Google Scholar : PubMed/NCBI
|
